1515 — China Resources Medical Holdings Balance Sheet
0.000.00%
- HK$4.69bn
- HK$6.72bn
- CNY9.85bn
- 69
- 80
- 68
- 86
Annual balance sheet for China Resources Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | Interim Report | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,972 | 2,635 | 3,424 | 1,236 | 977 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 930 | 963 | 2,725 | 1,676 | 1,456 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,147 | 3,925 | 6,766 | 3,429 | 3,239 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,046 | 2,118 | 5,418 | 5,362 | 5,272 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 8,963 | 10,468 | 17,818 | 13,654 | 13,318 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,207 | 3,444 | 5,124 | 5,207 | 4,499 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 2,858 | 4,017 | 8,308 | 7,842 | 7,105 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 6,105 | 6,451 | 9,509 | 5,812 | 6,214 |
Total Liabilities & Shareholders' Equity | 8,963 | 10,468 | 17,818 | 13,654 | 13,318 |
Total Common Shares Outstanding |